Literature DB >> 25300644

Can women determine the success of early medical termination of pregnancy themselves?

S T Cameron1, A Glasier2, A Johnstone2, H Dewart3, A Campbell3.   

Abstract

OBJECTIVE: To determine the outcome of early medical termination of pregnancy (TOP) among women who choose a "self assessment" follow up comprising a self-performed low sensitivity urine pregnancy test with instructions on signs/symptoms that mandate contacting the TOP service. STUDY
DESIGN: A retrospective review of computer databases of 1726 women choosing self-assessment after early medical TOP (<9 weeks) in the UK. The main outcome measures were (a) number of women choosing self-assessment, (b) contact rates with TOP service and (c) time to presentation with an ongoing pregnancy (failed TOP).
RESULTS: Ninety-six percent of women having an early medical TOP and going home to expel the pregnancy chose self-assessment. Two percent of women made unscheduled visits to the TOP service. One hundred and eighty-eight women (11%) telephoned the service about concerns related to complications or the success of treatment. There were eight ongoing pregnancies (0.5%; 95% confidence interval 0.2-0.9%). Four were detected within 4 weeks of treatment; the remainder were not detected until one or more missed menses after the procedure.
CONCLUSIONS: Most women having an early medical TOP, who go home to expel the pregnancy, choose self-assessment. Relatively few women make unscheduled visits or telephone the TOP service. Most ongoing pregnancies are recognized at an early stage, although late presentation (as with all methods of follow up) does still occur. IMPLICATIONS STATEMENT: If women are given clear instructions on how and when to conduct a urine pregnancy test and on signs/symptoms that mandate contacting the TOP service, then they can confirm the success of early medical TOP themselves. Late presentation due to failure to recognize an ongoing pregnancy is rare.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Low sensitivity pregnancy test; Medical abortion; Mifepristone; Misoprostol

Mesh:

Substances:

Year:  2014        PMID: 25300644     DOI: 10.1016/j.contraception.2014.09.009

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Telemedicine and medical abortion: dispelling safety myths, with facts.

Authors:  Roopan Gill; Wendy V Norman
Journal:  Mhealth       Date:  2018-02-01

Review 2.  Medication to Manage Abortion and Miscarriage.

Authors:  Jessica Beaman; Christine Prifti; Eleanor Bimla Schwarz; Mindy Sobota
Journal:  J Gen Intern Med       Date:  2020-05-14       Impact factor: 5.128

3.  Contraceptive care at the time of medical abortion: experiences of women and health professionals in a hospital or community sexual and reproductive health context.

Authors:  Carrie Purcell; Sharon Cameron; Julia Lawton; Anna Glasier; Jeni Harden
Journal:  Contraception       Date:  2015-10-03       Impact factor: 3.375

4.  Is self-assessment of medical abortion using a low-sensitivity pregnancy test combined with a checklist and phone text messages feasible in South African primary healthcare settings? A randomized trial.

Authors:  Deborah Constant; Jane Harries; Kristen Daskilewicz; Landon Myer; Kristina Gemzell-Danielsson
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

5.  Determinants of Antenatal Healthcare Utilisation by Pregnant Women in Third Trimester in Peri-Urban Ghana.

Authors:  Jones Asafo Akowuah; Peter Agyei-Baffour; Dadson Awunyo-Vitor
Journal:  J Trop Med       Date:  2018-02-15

6.  Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol.

Authors:  Li-Ping Song; Shi-Yan Tang; Cui-Lan Li; Lee-Jaden-Gil-Yu-Kang Zhou; Xue-Tang Mo
Journal:  J Obstet Gynaecol Res       Date:  2018-07-05       Impact factor: 1.730

7.  Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.

Authors:  Elizabeth G Raymond; Daniel Grossman; Alice Mark; Ushma D Upadhyay; Gillian Dean; Mitchell D Creinin; Leah Coplon; Jamila Perritt; Jessica M Atrio; DeShawn Taylor; Marji Gold
Journal:  Contraception       Date:  2020-04-16       Impact factor: 3.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.